Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

ASX/TTX stock hub

ASX/TTX has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

ASX/TTXis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

252.8M

Australian Securities Exchange

Market data

Live price

Current market quote for this ticker.

Current price

ASX/TTX

In the news

Latest news · ASX/TTX

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.9P50 20.4P75 41.2

Trailing P/En/a

P25 14.2P50 19.2P75 35.1

ROE-150

P25 -118.7P50 -49.4P75 -1.2

ROIC-21.5

P25 -74.7P50 -33.5P75 0.1

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All ASX/TTX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

152

Groups with data

Currency

AUD

Showing 152 of 152 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Australia
Country code	AU
Employees	15
Enterprise value	AUD 242.5M
Exchange	Australian Securities Exchange
Financial currency	AUD
First seen	2026-05-10
Industry	Biotechnology
Isin	AU0000400574
Last refreshed	2026-05-10
Market cap	AUD 252.8M
Price	AUD 4.98
Price currency	AUD
Rev Per Employee	133,183.6x
Sector	Healthcare
Sic	2836
Symbol	asx/TTX
Website	https://tetratherix.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-4.73%
EV Earnings	-20.26x
EV/FCF	-26.72x
EV/Sales	121.36x
FCF yield	-3.59%
P/B ratio	10.37x
P/S ratio	126.55x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	100%
Gross Profit	AUD 2M
Gross Profit Growth	89.79%
Gross Profit Growth Q	206.03%
Gross Profit Growth3 Y	32.25%
Net Income	AUD -12M
Pretax Margin	-598.96%
Profit Per Employee	AUD -797,712
ROA	-20.1
ROCE	-21.59
ROE	-150
ROIC	-21.49

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Revenue Growth	157.24x
Revenue Growth Q	206.04x
Revenue Growth3 Y	32.25x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	AUD 0.08
Assets	AUD 38.1M
Cash	AUD 21.6M
Current Assets	AUD 25M
Current Liabilities	AUD 2.1M
Debt	AUD 11.2M
Debt Equity	AUD 0.46
Debt FCF	AUD -1.23
Equity	AUD 24.4M
Interest Coverage	-27.79
Liabilities	AUD 13.7M
Long Term Assets	AUD 13M
Long Term Liabilities	AUD 11.6M
Net Cash	AUD 10.4M
Net Cash By Market Cap	AUD 4.1
Net Debt Equity	AUD -0.42
Tangible Book Value	AUD 23.6M
Tangible Book Value Per Share	AUD 0.47

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	12.13
Net Working Capital	AUD 2M
Quick ratio	11.89
Working Capital	AUD 23M
Working Capital Turnover	AUD 0.25

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-65.59%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
200-day SMA	4.16
50-day SMA	4.54
50-day SMA vs 200-day SMA	50over200
All Time High	5.8
All Time High Change	-14.14%
All Time High Date	2026-03-18
All Time Low	2.88
All Time Low Change	72.92%
All Time Low Date	2025-06-30
ATR	0.18
Beta1y	0.15
Ch YTD	51.83
High	5.1
High52	5.8
High52 Date	2026-03-18
High52ch	-14.14%
Low	4.93
Low52	2.88
Low52 Date	2025-06-30
Low52ch	72.92%
Ma50ch	9.6%
Price vs 200-day SMA	19.77%
RSI	57.8
RSI Monthly	0
RSI Weekly	60.6
Sharpe ratio	1.14x
Sortino ratio	2.03
Total Return	-65.59%
Tr YTD	51.83
Tr1m	16.36%
Tr1w	3.53%
Tr3m	34.6%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	AUD -7.8M
Operating margin	-389

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	10,363,849%
Net Borrowing	-9,918,915
Shares Insiders	42.1%
Shares Institutions	4.8%
Shares Out	50,765,665
Shares Qo Q	81.8%
Shares Yo Y	65.59%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	AUD -9.5M
Average Volume	5,901x
Bv Per Share	0.48
CAPEX	AUD -2.5M
Ch1m	16.36
Ch1w	3.53
Ch3m	34.6
Ch6m	24.81
Change	-0.4%
Change From Open	-2.35
Close	5
Days Gap	2
Depreciation Amortization	392,550
Dollar Volume	19,033.6
Earnings Date	2026-05-22
EBIT	AUD -7.8M
EBITDA	AUD -7.4M
EPS	AUD -0.31
F Score	2
FCF	AUD -9.1M
FCF EV Yield	-3.74x
FCF Per Share	AUD -0.18
Financing CF	22,268,820
Fiscal Year End	June
Founded	2,015
Investing CF	-3,364,288
Is Primary Listing	1
Last Earnings Date	2025-11-27
Last Report Date	2025-12-31
Ma150	4.11
Ma150ch	21.17%
Ma20	4.9
Ma20ch	1.72%
Net CF	12,340,822
Next Earnings Date	2026-05-22
Open	5.1
Position In Range	29.41
Ppne	11,298,898
Price Date	2026-05-08
Ptbv Ratio	10.71
Relative Volume	0.64x
Revenue	1,997,754x
SBC By Revenue	23.26x
Share Based Comp	464,632
Tr6m	24.81%
Volume	3,822
Z Score	8.24

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does ASX/TTX pay a dividend?

Capital-return profile for this ticker.

Ownership

Who owns ASX/TTX?

Insider, institutional, and short-interest positioning.

Institutional ownership

+4.8%

Share of float held by funds and institutions

Insider ownership

+42.1%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+65.6%

Negative means the company is buying back shares.

Technical

ASX/TTX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

57.8

Neutral momentum band

Price vs 200-day MA

+19.8%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

1.14

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About ASX/TTX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current asx/TTX stock rating?

asx/TTX is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full asx/TTX analysis?

The full report lives at /stocks/asx/TTX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for asx/TTX?

The latest report frames asx/TTX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the asx/TTX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.